Home > Insider Trading > Filing (0001209191-16-128886)

Filing Details

Accession Number:: 0001209191-16-128886
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-21 07:40:13
Reporting Period:: 2016-06-20

Filing Date:: 2016-06-21
Accepted Time:: 2016-06-21 07:40:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1460329	Idi Inc.	IDI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
898860	Al Et Md Phillip Frost	4400 Biscayne Boulevard Miami FL 33137		Yes	No	Yes	No
1380896	Trust Investments Gamma Frost	4400 Biscayne Boulevard, 15Th Floor Miami FL 33137		No	No	Yes	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-20	5,000	$4.65	15,634,773	No	4	P	Indirect	By Frost Gamma InvestmentsTrust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Frost Gamma InvestmentsTrust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,000,000	Indirect	By Frost Gamma Investments Trust

Footnotes

The shares were purchased in multiple transactions at prices ranging from $4.57 to $4.70, with a weighted average price per share of $4.65. The reporting person undertakes to provide IDI, Inc., any security holder of IDI, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the ranges set forth in this footnote.
These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole andexclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner ofFrost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the soleshareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of anypecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securitiesfor purposes of Section 16 or for any other purpose.
On December 8, 2015, the reporting person received a grant, subject to stockholder approval, of 3,000,000 restricted stock units ("RSUs"), convertible into common stock of the issuer on a one-for-one basis. Stockholder approval was obtained on June 1, 2016. The reporting person has elected to defer delivery of any vested RSUs until the reporting person's separation from service from the Company, a Change of Control of the Company, or death or disability.